Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16
Dynorphin A also serve as an agonist for other opioid receptors
It is used to induce genomic instability in mice and modification of the kinetics of growth of Gram-negative bacteria
is a potent and selective inhibitor of Jumonji AT-Rich Interactive Domain 1 (JARID1) histone demethylases
InChi: InChI=1S/C11H22O2/c1-3-5-6-7-9-10(8-4-2)11(12)13/h10H
5-g]quinazoline-2-thione dihydrochloride
(-)-Cevimeline hydrochloride hemihydrate Catalog No.:M34745-C Dynorphin A also serve as( ) Cevimeline hydrochloride hemihydrate (( ) SNI 2011), a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome. IC50 value: Target: mAChR The general pharmacol. properties of this drug on the gastrointestinal, urinary, and reproductive systems and other tissues were investigated in mice, rats, guinea pigs, rabbits, and dogs. The in vitro metab. of SNI 2011 was also evaluated with rat and dog liver
US$ 150.00
US$ 172.00
US$ 100.00
US$ 55.00
US$ 45.00
US$ 74.00